ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 189 filers reported holding ACADIA PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 1.07 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,654 | +1869.0% | 79,388 | +1397.9% | 0.00% | – |
| Q4 2022 | $84 | -100.0% | 5,300 | -64.2% | 0.00% | – |
| Q3 2022 | $242,000 | +227.0% | 14,802 | +179.3% | 0.00% | – |
| Q2 2022 | $74,000 | -82.1% | 5,300 | -69.0% | 0.00% | – |
| Q1 2022 | $414,000 | -79.5% | 17,100 | -80.2% | 0.00% | -100.0% |
| Q4 2021 | $2,016,000 | +58.6% | 86,393 | +68.2% | 0.00% | +100.0% |
| Q3 2021 | $1,271,000 | +1.9% | 51,352 | +0.4% | 0.00% | 0.0% |
| Q2 2021 | $1,247,000 | -46.8% | 51,152 | -43.7% | 0.00% | -75.0% |
| Q1 2021 | $2,344,000 | – | 90,857 | +320.3% | 0.00% | – |
| Q4 2020 | $0 | – | 21,618 | -1.9% | 0.00% | – |
| Q3 2020 | $0 | -100.0% | 22,045 | +103.5% | 0.00% | -100.0% |
| Q1 2020 | $457,000 | -60.2% | 10,834 | -59.7% | 0.00% | -66.7% |
| Q4 2019 | $1,148,000 | -53.0% | 26,854 | -60.4% | 0.00% | -57.1% |
| Q3 2019 | $2,440,000 | +176.3% | 67,820 | +105.2% | 0.01% | +250.0% |
| Q2 2019 | $883,000 | -51.7% | 33,045 | -51.5% | 0.00% | -60.0% |
| Q1 2019 | $1,830,000 | +229.7% | 68,181 | +98.3% | 0.01% | +150.0% |
| Q4 2018 | $555,000 | -23.8% | 34,376 | -2.0% | 0.00% | 0.0% |
| Q3 2018 | $728,000 | +86.7% | 35,073 | +37.3% | 0.00% | 0.0% |
| Q2 2018 | $390,000 | +28.7% | 25,548 | +153.5% | 0.00% | -84.6% |
| Q4 2017 | $303,000 | -62.1% | 10,077 | -52.5% | 0.01% | -60.6% |
| Q3 2017 | $799,000 | -59.5% | 21,226 | -70.0% | 0.03% | -61.6% |
| Q2 2017 | $1,971,000 | +25.5% | 70,683 | +54.7% | 0.09% | +26.5% |
| Q1 2017 | $1,570,000 | +1265.2% | 45,691 | +1040.0% | 0.07% | +871.4% |
| Q4 2016 | $115,000 | -83.8% | 4,008 | -82.0% | 0.01% | -85.4% |
| Q3 2016 | $709,000 | -9.2% | 22,315 | -7.4% | 0.05% | -7.7% |
| Q2 2016 | $781,000 | +984.7% | 24,090 | +828.0% | 0.05% | +766.7% |
| Q1 2016 | $72,000 | -76.3% | 2,596 | -69.6% | 0.01% | -75.0% |
| Q4 2015 | $304,000 | +360.6% | 8,543 | +321.7% | 0.02% | +380.0% |
| Q3 2015 | $66,000 | +57.1% | 2,026 | +98.2% | 0.01% | +25.0% |
| Q2 2015 | $42,000 | – | 1,022 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 27,228,338 | $611,821,000 | 5.19% |
| First Washington CORP | 176,950 | $3,976,000 | 2.06% |
| SECTORAL ASSET MANAGEMENT INC | 783,424 | $17,604,000 | 1.93% |
| HARVEY CAPITAL MANAGEMENT INC | 219,042 | $4,921,000 | 1.84% |
| Ghost Tree Capital, LLC | 400,000 | $8,988,000 | 1.82% |
| Opus Point Partners Management, LLC | 36,733 | $825,000 | 1.62% |
| Palo Alto Investors LP | 1,650,780 | $37,093,000 | 1.59% |
| EMORY UNIVERSITY | 84,714 | $1,904,000 | 1.36% |
| GARRISON BRADFORD & ASSOCIATES INC | 69,000 | $1,550,000 | 1.32% |
| HealthCor Management, L.P. | 1,378,000 | $30,964,000 | 1.05% |